AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 MAY 8 - (NewsRx.com & NewsRx.net) -- Women with breast cancer who are considering treatment with adjuvant chemotherapy may benefit in decision making from the use of a formal decision aid, according to a new study.
The study found that the addition of a decision aid to a doctor's consultation improved patients' knowledge about their disease and increased their satisfaction with the decision-making process.
Decision aids are designed to help patients make more informed decisions about their treatment. Decision aids help explain different treatment options and provide quantitative estimates of risks and benefits. They also tailor information to individual patients while encouraging them to consider their own values when making decisions about their treatment. For this study, the decision aid consisted of a visual aid and written materials administered by a nurse during the medical consultation.
Timothy Whelan, MD, of the Hamilton Regional Cancer Centre in Ontario, and his colleagues conducted a randomized trial to determine the effectiveness of a decision aid called the Decision Board in helping patients with lymph node-negative breast cancer understand their disease and treatment options. Their findings were published in the Journal of the National Cancer Institute.
The study involved 176 women randomly assigned to receive either Decision Board plus medical consultation or medical consultation alone. One week after the end of the consultation, patients completed a questionnaire assessing their knowledge about breast cancer and satisfaction with decision making.
Patients who received the Decision Board had a better understanding of their disease, risk of cancer recurrence, and treatment options compared with patients who received medical consultation alone. Patients who received the Decision Board also reported being more satisfied with the decision-making process than patients in the usual care group. The Decision Board also ...
Source: HighBeam Research, Decision tool benefits women considering adjuvant chemotherapy.